Senior Product Manager for Functional Genomics, Thermo Fisher Scientific
BIOGRAPHY
APR 30, 2020 9:00 AM PDT
Tools and methods for CRISPR-Cas9 screening for functional genomics and drug discovery
Event Date & Time
DATE: April 30, 2020
TIME: 9:00am PT, 12:00pm ET
Abstract
Loss-of-function studies are an established method for uncovering a gene’s role in a biological pathway or disease state. The advent of CRISPR-Cas9 for gene knockout has given researchers a powerful tool for single-gene studies as well as high-throughput screening applications. Some experimental systems and assays demand solutions that enable long-term phenotypic readout, delivery into difficult-to-transfect cells, and the ability to easily move from pooled to arrayed screening reagents. The Invitrogen™ lentiviral guide RNA portfolio offers a toolset to achieve these goals. We will additionally present a recent case study of how a screen with LentiArray™ gRNA reagents has led to a potential human cancer therapeutic.
Learning Objectives:
- Guidelines to determine the CRISPR-Cas9 reagents that are best suited for your experiment
- The importance of proper controls and assay optimization when using a lentiviral CRISPR-Cas9 screening approach
- How arrayed lentiviral CRISPR sgRNA enable long-term assays for phenotypic screening
Webinars will be available for unlimited on-demand viewing after live event.
LabRoots is approved as a provider of continuing education programs in the clinical laboratory sciences by the ASCLS P.A.C.E. ® Program. By attending this webinar, you can earn 1 Continuing Education credit once you have viewed the webinar in its entirety.
You May Also Like
OCT 02, 2024 | 7:30 AM
De novo gene synthesis and protein expression are established technologies that can give access to nearly any target DNA or protein sequence, allowing for engineering of biologics. In this p...
DEC 10, 2024 | 9:00 AM
To-date, proteomic analysis has been severely limited in scale and resolution. Analyzing protein samples using an intact, single-molecule approach holds th...
Loading Comments...